As of February 2026 Apellis Pharmaceuticals has a market cap of A$3.97 Billion. This makes Apellis Pharmaceuticals the world's 4182th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 18th, 2026 the market cap of Apellis Pharmaceuticals was reported to be: